Awards and Rankings

Hogan Lovells Antitrust and Competition Lawyers Recognized as 2022 Thought Leaders and Future Leaders

Who’s Who Legal has recognized 29 Hogan Lovells antitrust and competition lawyers globally in its “2022 Market Insight” guide.

Press Releases

Hogan Lovells represents Intellia Therapeutics in life sciences collaboration to create new T-Cell therapy company

Munich, 16 July 2021 – Global law firm Hogan Lovells represents Intellia Therapeutics in the launch of a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell...

Press Releases

Hogan Lovells advises PerkinElmer, Inc. on the acquisition of SIRION BIOTECH GmbH

Led by Head of the Munich Corporate Group Lutz Angerer, international law firm Hogan Lovells has advised listed US company PerkinElmer, Inc. on the acquisition of SIRION BIOTECH GmbH, a...

Press Releases

Hogan Lovells advises AKASOL AG on takeover by BorgWarner

Led by Frankfurt-based partner Michael Schlitt and Tim Brandi, Hogan Lovells advised AKASOL AG (“AKASOL”) on the voluntary public takeover offer of ABBA BidCo AG, a subsidiary...

Press Releases

Hogan Lovells advises Gilead Sciences in long-acting HIV therapy collaboration agreement with Merck

Northern Virginia, Washington D.C., Brussels, 17 March 2021 – A team from global law firm Hogan Lovells has advised Gilead Sciences on its recently announced collaboration agreement with...

Press Releases

Hogan Lovells represents Rotana Music in landmark Warner Music investment

Washington, D.C., 23 February 2020 – Global law firm Hogan Lovells represented HRH Prince Alwaleed’s Rotana Music in connection with the Warner Music Group’s agreement to buy a minority...

Press Releases

Hogan Lovells advises TUI AG on its 500 million euro capital increase

Led by Frankfurt-based partner Michael Schlitt, international law firm Hogan Lovells advised TUI AG on its approximately €500 million rights issue ("Rights Issue"). In the course of...

Press Releases

Hogan Lovells advises Jennewein shareholders on its dual-track exit

Led by partners Peter Huber and Michael Schlitt, international law firm Hogan Lovells has advised the shareholders of Jennewein Biotechnologie GmbH on its EUR 310 million merger with Danish ...

Loading data